Benjamin Besse, MD, PhD, Institut Gustave Roussy, Villejuif, France, gives us an update on the work of the European Organization for Research and Treatment of Cancer (EORTC) Lung Cancer Group. Dr Besse highlights the report on the definition of oligometastatic disease, two key studies and the molecular screening of patients. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.